← Back
$ADMA All transactions

ADMA BIOLOGICS, INC.

F

$ Value

$833K

Shares

54,858

Price

$15

Filed

Mar 2

Insider

Name

Grossman Adam S

Title

President and CEO

CIK

0001542517

Roles

Director Officer

Transaction Details

Transaction Date

2026-02-26

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

2,204,728

Footnotes

Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units ("RSUs"). This is not an open market sale of securities. | Includes, as of the transaction date, (i) 282,529 unvested RSUs granted on February 9, 2026, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (ii) 189,017 unvested RSUs out of 252,022 RSUs granted on February 19, 2025, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; | (continued from footnote 2) (iii) 278,864 unvested RSUs out of 557,728 RSUs granted on February 26, 2024, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (iv) 286,848 unvested RSUs out of 573,695 RSUs granted on March 6, 2023 that will vest quarterly on each annual anniversary of the date of grant, over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; | (continued from footnote 3) (v) 75,000 unvested RSUs out of 300,000 RSUs granted on March 7, 2022 that will vest quarterly on each annual anniversary of the date of grant, over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; and (vi) 1,092,470 shares of common stock owned by the Reporting Person, which reflects prior purchases and the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes. | These shares are owned by Areth, LLC ("Areth"). The Reporting Person is a control person of Areth. | These shares are owned by Hariden, LLC ("Hariden"). The Reporting Person is the managing member of Hariden.

Filing Info

Accession No.

0001140361-26-007406

Form Type

4

Issuer CIK

0001368514

Grossman Adam S's History

Date Ticker Type Value
2026-03-16 ADMA M $81K
2026-03-16 ADMA $227K
2026-03-16 ADMA $91K
2026-03-16 ADMA M $0
2026-03-07 ADMA F $454K
2026-03-06 ADMA F $869K
2026-02-26 ADMA F $833K
2026-02-19 ADMA F $405K
2026-02-17 ADMA M $81K
2026-02-17 ADMA $241K

Other Insiders at ADMA (90d)

Insider Bought Sold Last
ELMS STEVE $217K 2026-03-06
Grossman Adam S
President and CEO
$656K 2026-03-16
Grossman Jerrold B 2026-02-09
Guiheen Lawrence P. 2026-03-17
FINGER ALISON CECILY 2026-02-09
KWON YOUNG 2026-02-09
Salas Eduardo Rene 2026-02-09
Kestenberg-Messina Kaitlin M.
COO and SVP, Compliance
$158K 2026-04-01
Tade Brad L.
CFO and Treasurer
2026-02-19